AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1
The disclosure provides FOXO1 inhibitors having beneficial properties such as selectivity and metabolic stability. FOXO1 inhibitors are useful in the treatment of diabetes.
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DEVITA, Robert J BELVEDERE, Sandro LIN, Hua Viola JOHNSTONE, Shawn TURCOTTE, Stephane |
description | The disclosure provides FOXO1 inhibitors having beneficial properties such as selectivity and metabolic stability. FOXO1 inhibitors are useful in the treatment of diabetes. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4217355A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4217355A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4217355A13</originalsourceid><addsrcrecordid>eNrjZLB2dHf1CwlWcPMPUgjxcFUICXJ1DPEFCin4uym4eAa7Oga7Bis4RSp4-nl4OnmGePr7gWTc_CP8DXkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgImRobmxqamjoTERSgBoCCiO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1</title><source>esp@cenet</source><creator>DEVITA, Robert J ; BELVEDERE, Sandro ; LIN, Hua Viola ; JOHNSTONE, Shawn ; TURCOTTE, Stephane</creator><creatorcontrib>DEVITA, Robert J ; BELVEDERE, Sandro ; LIN, Hua Viola ; JOHNSTONE, Shawn ; TURCOTTE, Stephane</creatorcontrib><description>The disclosure provides FOXO1 inhibitors having beneficial properties such as selectivity and metabolic stability. FOXO1 inhibitors are useful in the treatment of diabetes.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230802&DB=EPODOC&CC=EP&NR=4217355A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230802&DB=EPODOC&CC=EP&NR=4217355A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEVITA, Robert J</creatorcontrib><creatorcontrib>BELVEDERE, Sandro</creatorcontrib><creatorcontrib>LIN, Hua Viola</creatorcontrib><creatorcontrib>JOHNSTONE, Shawn</creatorcontrib><creatorcontrib>TURCOTTE, Stephane</creatorcontrib><title>AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1</title><description>The disclosure provides FOXO1 inhibitors having beneficial properties such as selectivity and metabolic stability. FOXO1 inhibitors are useful in the treatment of diabetes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB2dHf1CwlWcPMPUgjxcFUICXJ1DPEFCin4uym4eAa7Oga7Bis4RSp4-nl4OnmGePr7gWTc_CP8DXkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgImRobmxqamjoTERSgBoCCiO</recordid><startdate>20230802</startdate><enddate>20230802</enddate><creator>DEVITA, Robert J</creator><creator>BELVEDERE, Sandro</creator><creator>LIN, Hua Viola</creator><creator>JOHNSTONE, Shawn</creator><creator>TURCOTTE, Stephane</creator><scope>EVB</scope></search><sort><creationdate>20230802</creationdate><title>AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1</title><author>DEVITA, Robert J ; BELVEDERE, Sandro ; LIN, Hua Viola ; JOHNSTONE, Shawn ; TURCOTTE, Stephane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4217355A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>DEVITA, Robert J</creatorcontrib><creatorcontrib>BELVEDERE, Sandro</creatorcontrib><creatorcontrib>LIN, Hua Viola</creatorcontrib><creatorcontrib>JOHNSTONE, Shawn</creatorcontrib><creatorcontrib>TURCOTTE, Stephane</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEVITA, Robert J</au><au>BELVEDERE, Sandro</au><au>LIN, Hua Viola</au><au>JOHNSTONE, Shawn</au><au>TURCOTTE, Stephane</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1</title><date>2023-08-02</date><risdate>2023</risdate><abstract>The disclosure provides FOXO1 inhibitors having beneficial properties such as selectivity and metabolic stability. FOXO1 inhibitors are useful in the treatment of diabetes.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP4217355A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
title | AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T08%3A33%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEVITA,%20Robert%20J&rft.date=2023-08-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4217355A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |